“PhaseBio Pharmaceuticals, Inc., a leading company in the field of biopolymer-based drugs and focused on developing treatments for metabolic and specialty cardiopulmonary disorders, today announced that it has closed a $40 million Series C financing round led by AstraZeneca. Investment by AstraZen
“PhaseBio Pharmaceuticals, Inc., a leading company in the field of biopolymer-based drugs and focused on developing treatments for metabolic and specialty cardiopulmonary disorders, today announced that it has closed a $40 million Series C financing round led by AstraZeneca. Investment by AstraZen
このブックマークにはスターがありません。
最初のスターをつけてみよう！
PhaseBio Raises $40 Million Series C Financing Led by AstraZeneca
1 人がブックマーク・1 件のコメント
＼ コメントが サクサク読める アプリです ／